Logo-npj

Review

1. Significance of diet in chronic kidney disease
Chaudhary Muhammad Junaid Nazar*
J Nephropharmacol. 2013;2(2): 37-43.
Article
PDF
XML
Cited By:
News and Views

2. Quality of life in different geographic areas; sharing an experience
Behzad Einollahi, Mohsen Motalebi*
J Nephropharmacol. 2013;2(2): 47-48.
Article
PDF
XML
Cited By:
Hypothesis

3. The role of herbal medicines in treatment of urinary tract diseases
Ahmad-Reza Gohari, Soodabeh Saeidnia*
J Nephropharmacol. 2014;3(1): 13-14.
Article
PDF
XML
Cited By:
Epidemiology and Prevention

4. Administration of antioxidants in chronic kidney disease
Mohamad Reza Tamadon, Mehrdad Zahmatkesh, Seyed Seifollah Beladi Mousavi*
J Nephropharmacol. 2015;4(1): 9-11.
Article
PDF
XML
Cited By:
Case Report

5. Platelet satellitism in chronic renal failure: an experimental study
Vibha Gupta*, Shahbaj Ahmad, Harish Chandra, Vikas Shrivastava
J Nephropharmacol. 2015;4(1): 13-15.
Article
PDF
XML
Cited By:
Review

6. Does frequent hemodialysis regimen results in regression of left ventricular mass compared to conventional hemodialysis?
Chaudhary Muhammad Junaid Nazar*, Faisal Bashir, Syed Ahtizaz Ahmed, Saba Izhar
J Nephropharmacol. 2015;4(1): 37-41.
Article
PDF
XML
Cited By:
Epidemiology and Prevention

7. Lycopene and kidney; future potential application
Zahra Taheri, Mahin Ghafari, Masoud Amiri*
J Nephropharmacol. 2015;4(2): 49-51.
Article
PDF
XML
Cited By:
Review

8. Adiponectin and chronic kidney disease; a review on recent findings
Maryam Heidari, Parto Nasri, Hamid Nasri*
J Nephropharmacol. 2015;4(2): 63-68.
Article
PDF
XML
Cited By:
Original

9. Awareness and beliefs towards organ donation in chronic kidney disease patients in western India
Manish R Balwani*, Vivek B. Kute, Himanshu Patel, Pankaj R. Shah, Jitendra Goswami, Pravin Ghule, Maulin Shah, Vipul Gattani, Hargovind L. Trivedi
J Nephropharmacol. 2015;4(2): 57-60.
Article
PDF
XML
Cited By:
Hypothesis

10. Nitric oxide synthase and polycystic kidney disease
Viroj Wiwanitkit*
J Nephropharmacol. 2015;4(2): 85-87.
Article
PDF
XML
Cited By:
Editorial

11. Racial disparities in chronic kidney diseases in the United States; a pressing public health challenge with social, behavioral and medical causes
Shervin Assari*
J Nephropharmacol. 2016;5(1): 4-6.
Article
PDF
XML
Cited By:
Original

12. Endothelin 1 gene is not a major modifier of chronic kidney disease advancement among the autosomal dominant polycystic kidney disease patients
Shiva Nagendra Reddy Annapareddy, Ramprasad Elumalai*, Bhaskar V.K.S. Lakkakula, Gnanasambandan Ramanathan, Soundararajan Periyasamy
J Nephropharmacol. 2016;5(1): 13-18.
Article
PDF
XML
Cited By:
Commentary

13. The modifiers of chronic kidney disease in autosomal dominant polycystic kidney disease and the role of the endothelin-1
Behzad Einollahi, Aidin Lotfiazar*
J Nephropharmacol. 2016;5(1): 24-25.
Article
PDF
XML
Cited By:
Review

14. Efficacy of dietary interventions in end-stage renal disease patients; a systematic review
Chaudhary Muhamamd Juniad Nazar*, Micheal Mauton Bojerenu, Muhammad Safdar, Armughan Ahmed, Muhammad Hammad Akhtar, Tiffany Billmeier Kindratt
J Nephropharmacol. 2016;5(1): 28-40.
Article
PDF
XML
Cited By:
Review

15. Pathways, perspectives and pursuits in polycystic kidney disease
L. V. K. S. Bhaskar*, Ramprasad Elumalai, Soundararajan Periasamy
J Nephropharmacol. 2016;5(1): 41-48.
Article
PDF
XML
Cited By:
Case Report

16. An unusual cause of renal failure; Epstein syndrome
Manish R Balwani*, Divyesh P Engineer, Manoj R Gumber, Vivek B Kute, Rajesh Singh, Himanshu V Patel, Aruna V Vanikar, Dinesh Gera, Pankaj R Shah, Hargovind L Trivedi
J Nephropharmacol. 2016;5(1): 63-65.
Article
PDF
XML
Cited By:
Review

17. Diabetic kidney disease: world wide difference of prevalence and risk factors
Osama Gheith*, Nashwa Farouk, Narayanan Nampoory, Medhat A Halim, Torki Al-Otaibi
J Nephropharmacol. 2016;5(1): 49-56.
Article
PDF
XML
Cited By:
Mini-Review

18. Chronic kidney disease and obesity; a mini-review to the current knowledge
Leila Mahmoodnia, Sara Beigrezaei*
J Nephropharmacol. 2017;6(2): 30-32. doi: 10.15171/npj.2017.01
Article
PDF
XML
Cited By:
4
Case Series

19. Hospital-acquired nephrotoxic exposures in the precipitation of acute kidney injury – A case series analysis and a call for more preventative nephrology practices
Macaulay Amechi Onuigbo*, Eileen Samuel, Nneoma Agbasi
J Nephropharmacol. 2017;6(2): 90-97. doi: 10.15171/npj.2017.11
Article
PDF
XML
Cited By:
0
Original

20. Albuminuria in patients with young onset type 2 diabetes
Yassamine Bentata*, Redouane Abouqal
J Nephropharmacol. 2017;6(2): 110-113. doi: 10.15171/npj.2017.14
Article
PDF
XML
Cited By:
0
Original

21. The effect of allopurinol on the progression of chronic kidney disease
Aygul Ozdemir, Ayca Inci*
J Nephropharmacol. 2017;6(2): 138-141. doi: 10.15171/npj.2017.21
Article
PDF
XML
Cited By:
0
Editorial

22. Hyperuricemia; a warning sign of future cardiovascular events and chronic kidney disease
Farahnak Assadi*
J Nephropharmacol. 2018;7(1): 1-2. doi: 10.15171/npj.2018.01
Article
PDF
XML
Cited By:
0
Mini-Review

23. Impact of vitamin D deficiency on health with regard to kidney disease; an updated mini-review
Nozar Dorestan, Sara Bahadoram, Mohammad Bahadoram, Mohammadreza Khosravi, Mohammad Davoodi, Ali Hasanpour Dehkordi, Zaher Khazaei, Masoud Amiri*
J Nephropharmacol. 2018;7(2): 55-60. doi: 10.15171/npj.2018.13
Article
PDF
XML
Cited By:
0
Case Report

24. The demise of contrast nephropathy; can this be true? A contrarian view; a representative case report of contrast nephropathy from Mayo Clinic Health System in Northwestern Wisconsin
Macaulay Amechi Onuigbo*, Eileen Samuel, Nneoma Agbasi
J Nephropharmacol. 2018;7(2): 68-73. doi: 10.15171/npj.2018.16
Article
PDF
XML
Cited By:
0
Original

25. Prevalence and characteristics of diabetic kidney disease in type 2 diabetic patients in Abidjan, Côte d’Ivoire
Sindou Sanogo, Serge Didier Konan, Kouamé Hubert Yao*, Emma Kouassi, Séry Patrick Diopoh, Jean Aka, Randolphe Niava, Amos Ankotche
J Nephropharmacol. 2018;7(2): 98-103. doi: 10.15171/npj.2018.21
Article
PDF
XML
Cited By:
0
Original

26. Evaluation and comparison of quality of life and its related factors in pre-dialysis and hemodialysis patients 
Mohammad Reza Tamadon*, Sajad Hasani, Ensieh Farhidzadeh, Majid Mirmohammadkhani
J Nephropharmacol. 2018;7(2): 114-121. doi: 10.15171/npj.2018.24
Article
PDF
XML
Cited By:
0
Original

27. The effect of coenzyme Q10 on cognitive status in chronic hemodialysis patients; a double-blind, randomized, clinical trial
Mohammad Reza Tamadon*, Majid Mirmohammadkhani, Shahb Rafaati
J Nephropharmacol. 2018;7(2): 149-155. doi: 10.15171/npj.2018.30
Article
PDF
XML
Cited By:
0
Original

28. Rapid assessment of physical activity score in maintenance hemodialysis patients with nutritional assessment
Vinitha Varghese ORCID, Madhusudan Vijayan, Georgi Abraham* ORCID, Sam Nishanth, Milly Mathew, Rajeevalochana Parthasarathy, Nevin Mancha
J Nephropharmacol. 2019;8(1): e01. doi: 10.15171/npj.2019.01
Scopus ID: 85076570238    
Article
PDF
XML
Cited By:
3
2
Original

29. On the estimation of misclassification probabilities of chronic kidney disease using continuous time hidden Markov models 
Gurprit Grover, Alka Sabharwal, Shrawan Kumar*, Arpan Kumar Thakur
J Nephropharmacol. 2019;8(1): e07. doi: 10.15171/npj.2019.07
Scopus ID: 85089282151    
Article
PDF
XML
Cited By:
1
2
Original

30. Caregiver burden among family caregivers of older patients receiving hemodialysis and its relevant factors
Mojtaba Senmar, Hossein Rafiei*, Fateme Yousefi, Ali Razaghpoor, Mohammad Bokharaei
J Nephropharmacol. 2019;8(1): e12. doi: 10.15171/npj.2019.12
Article
PDF
XML
Cited By:
9
Review

31. Association of fetuin-A with kidney disease; a review on current concepts and new data
Marziyeh Akbari ORCID, Hashem Nayeri* ORCID, Hamid Nasri
J Nephropharmacol. 2019;8(2): e14. doi: 10.15171/npj.2019.14
Article
PDF
XML
Cited By:
3
Original

32. Statistical significance of prognostic factors on the progression of chronic kidney disease through simulation study
Alka Sabharwal, Gurprit Grover, Shrawan Kumar*
J Nephropharmacol. 2019;8(2): e20. doi: 10.15171/npj.2019.20
Article
PDF
XML
Cited By:
0
Original

33. Glomerular filtration rate evaluation and its comparison with international standard values in a large populationbased study
Seyed Javad Hoseini ORCID, Ehsan Mosa Farkhani, Hamid Reza Bahrami, Reza Eftekhari Gol, Saied Bokaie, Behnaz Beygi*
J Nephropharmacol. 2019;8(2): e23. doi: 10.15171/npj.2019.23
Article
PDF
XML
Cited By:
1
Original

34. Correlation of serum soluble Klotho with fibroblast growth factor 23 levels in chronic kidney disease patients; a single centre study
Yuvaraj Anand, Vijayan Madhusudan, Parthasarathy Rajeevalochana, Mathew Milly, George Deepu, Abraham Georgi*
J Nephropharmacol. 2020;9(1): e08. doi: 10.15171/npj.2020.08
Scopus ID: 85087319817    
Article
PDF
XML
Cited By:
1
0
Original

35. Knowledge and practices about hemodialysis among dialysis technicians in western part of India
Manish R Balwani* ORCID, Jigar Shrimali ORCID, Amit Pasari ORCID, Jay Shah ORCID, Vivek Kute ORCID
J Nephropharmacol. 2020;9(1): e04. doi: 10.15171/npj.2020.04
Scopus ID: 85084859403    
Article
PDF
XML
Cited By:
0
0
Brief Report

36. Dialysis dose in end-stage renal disease patients undergoing regular hemodialysis at Ibn-Sena and AlNao hospitals in Sudan
Essamaddin A Ibrahim* ORCID
J Nephropharmacol. 2020;9(1): e10. doi: 10.15171/npj.2020.10
Scopus ID: 85084829228    
Article
PDF
XML
Cited By:
1
0
Original

37. Investigation of factors related to N-terminal pro-B type natriuretic peptide levels in hemodialysis patients; a single center study
Farbod Bonakdar, Pegah Noorshargh ORCID, Parin Hedayati, Hamid Nasri* ORCID
J Nephropharmacol. 2020;9(1): e05. doi: 10.15171/npj.2020.05
Scopus ID: 85084792620    
Article
PDF
XML
Cited By:
0
0
Review

38. Darbepoetin in chronic kidney disease and dialysis patients; an updated review of outcomes
Tarun Kumar Jeloka* ORCID, Datta Jayanta, Suresh Babu Vallamkonda, Sujeet Narayan Charugulla, Gupta Namita
J Nephropharmacol. 2020;9(2): e14. doi: 10.34172/npj.2020.14
Scopus ID: 85086044411    
Article
PDF
XML
Cited By:
0
0
Original

39. Spectrum of renal biopsies; a three-year data from a tertiary care centre of eastern India
Chetan Mahajan ORCID, Vaibhav Tiwari ORCID, Smita Subhash Divyaveer* ORCID, Malagouda R Patil ORCID, Avinandan Banerjee ORCID, Vishnuvardhan Bagur, Umesh Dubey, Koushik Battacharjee, Sandeep Saini, Tanima Das Bhattacharya ORCID, Arpita Raychaudhury ORCID, Sanjay Dasgupta ORCID, Dipankar Sarkar ORCID, Anila Abraham Kurien ORCID, Rajendra Pandey
J Nephropharmacol. 2020;9(2): e20. doi: 10.34172/npj.2020.20
Scopus ID: 85085942814    
Article
PDF
Suppl 1
XML
Cited By:
3
3
Review

40. Perspectives on the relationship of renal disease and coronavirus disease 2019
Banafsheh Yalameha ORCID, Bijan Roshan ORCID, Lakkakula VKS Bhaskar ORCID, Leila Mohmoodnia* ORCID
J Nephropharmacol. 2020;9(2): e22. doi: 10.34172/npj.2020.22
Scopus ID: 85085931964    
Article
PDF
XML
Cited By:
18
21
Mini-Review

41. Covid-19 and kidney; a mini-review on current concepts and new data
Elaheh Keivani Boroujeni ORCID, Steven James Kellner ORCID, Aiyoub Pezeshgi* ORCID
J Nephropharmacol. 2021;10(1): e01. doi: 10.34172/npj.2021.01
Scopus ID: 85090653016    
Article
PDF
XML
Cited By:
6
4
Mini-Review

42. The impact of metformin in chronic kidney disease-mineral and bone disorder
Rohollah Masumi, Ramin Tolouian ORCID, Audrey Tolouian ORCID, Leila Mohmoodnia* ORCID
J Nephropharmacol. 2021;10(1): e02. doi: 10.34172/npj.2021.02
Scopus ID: 85090617264    
Article
PDF
XML
Cited By:
0
0
Original

43. The effects of sevelamer carbonate on blood glucose and inflammatory factors in patients with diabetic kidney disease; a controlled clinical trial
Shadi Botshekan ORCID, Leila Mahmoodnia* ORCID, Ali Momeni ORCID, Tina Jafari ORCID, Ali Hasanpour Dehkordi* ORCID, Mohammadsaleh Ghafari Goosheh ORCID
J Nephropharmacol. 2021;10(2): e10. doi: 10.34172/npj.2021.10
Scopus ID: 85111597471    
Article
PDF
XML
Cited By:
0
0
Mini Review

44. Strive for kidney health for everyone during COVID-19; the possible theme for the world kidney day 2021
Elahe Aleebrahim-Dehkordi ORCID, Elaheh Mazaheri ORCID, Bijan Roshan ORCID, Bhaskar VKS Lakkakula ORCID, Ali Hasanpour-Dehkordi*, Maryam Khosravian ORCID, Aiyoub Pezeshgi* ORCID
J Nephropharmacol. 2021;10(2): e12. doi: 10.34172/npj.2021.12
Scopus ID: 85111439886    
Article
PDF
XML
Cited By:
2
1

Original

45. A comparative study on the effect of calcitriol and cinacalcet on hyperparathyroidism in hemodialysis patients; a double-blinded randomized clinical trial
Saeed Mardani* ORCID, Faranak Sadat Filsouf ORCID
J Nephropharmacol. 2022;11(1): e12. doi: 10.34172/npj.2022.12
Scopus ID: 85119625471    
Article
PDF
XML
Cited By:
0
0

Original

46. Correlation of glomerular filtration rate and fibroblast growth factor-23 levels in chronic kidney disease; sub analysis chronic kidney disease–mineral and bone disorder study
Akiko Syawalidhany Tahir* ORCID, Haerani Rasyid ORCID, Syakib Bakri ORCID, Hasyim Kasim ORCID, Tutik Harjianti ORCID, Muhammad Luthfi Parewangi ORCID, Harun Iskandar ORCID, Arifin Seweng ORCID
J Nephropharmacol. 2024;13(1): e10446. doi: 10.34172/npj.2022.10446
Scopus ID: 85179348214    
Article
PDF
XML
Cited By:
0
0
Review

47. Ameliorative effects of pirfenidone in chronic kidney disease

Samad Ghodrati ORCID, Yeganeh Ragati Haghi ORCID, Jyoti Baharani ORCID, Akshaya Joseph ORCID, Niloufar Alimohammadi ORCID, Farzad Koosha ORCID, Leila Mostafavi ORCID, Aiyoub Pezeshgi* ORCID
J Nephropharmacol. 2022;11(2): e10458. doi: 10.34172/npj.2022.10458
Scopus ID: 85134050498    
Article
PDF
XML
Cited By:
0
1

Original

48. Hemodialysis catheter-related bloodstream infections: a single-center experience
Mohan V Bhojaraja ORCID, Ravindra Attur Prabhu* ORCID, Shankar Prasad Nagaraju ORCID, Indu Ramachandra Rao ORCID, Srinivas Vinayak Shenoy ORCID, Dharshan Rangaswamy ORCID, Veena Natti Krishna ORCID, Megha Nagaraj Nayak ORCID
J Nephropharmacol. 2023;12(2): e10475. doi: 10.34172/npj.2022.10475
Scopus ID: 85162031229    
Article
PDF
XML
Cited By:
0
6
Original

49. Evaluating risk factors for catheter-related infections in hemodialysis patients
Sepideh Hajian* ORCID, Moosa Seifzade ORCID
J Nephropharmacol. 2022;11(2): e10489. doi: 10.34172/npj.2022.10489
Article
PDF
XML
Cited By:
0
Review

50. Recurrence of rare disease after kidney transplant
Farahnoosh Farnood ORCID, Seyyedeh Mina Hejazian ORCID, Kamal Boostani ORCID, Alireza Mardomi ORCID, Mohammadreza Ardalan* ORCID
J Nephropharmacol. 2023;12(1): e10519. doi: 10.34172/npj.2022.10519
Scopus ID: 85146791012    
Article
PDF
XML
Cited By:
0
1
Meta Analysis

51. Effect of allopurinol on the treatment of chronic kidney disease: a systematic review and meta-analysis
Aiyoub Pezeshgi ORCID, Sattar Jafari, Shabnam Pouladvand ORCID, Negin Parsamanesh ORCID, Samad Ghodrati* ORCID, Hamid Nasri* ORCID
J Nephropharmacol. 2023;12(1): e10566. doi: 10.34172/npj.2022.10566
Scopus ID: 85146817118    
Article
PDF
XML
Cited By:
0
0
Clinical Trial

52. Effect of niacin on phosphorus, calcium, parathormone and vitamin D levels in hemodialysis patients; a double-blinded randomized clinical trial
Ali Mohamadi Najafabadi ORCID, Ali Ahmadi, Saeed Mardani* ORCID
J Nephropharmacol. 2023;12(1): e10569. doi: 10.34172/npj.2022.10569
Scopus ID: 85146747775    
Article
PDF
XML
Cited By:
0
0
Review

53. Kidney injury molecule-1; is it a predictive marker for renal diseases?
Deepashree Goravigere Anandkumar ORCID, Prashant Chippalkatti Dheerendra ORCID, Deepesh Vellakampadi ORCID, Gnanasambandan Ramanathan* ORCID
J Nephropharmacol. 2023;12(2): e10572. doi: 10.34172/npj.2023.10572
Scopus ID: 85162141996    
Article
PDF
XML
Cited By:
0
3
Case Report

54. A mathematical analysis of dialysis report and kidney function tests; a case study
Amir Barhoi* ORCID
J Nephropharmacol. 2024;13(1): e10600. doi: 10.34172/npj.2023.10600
Scopus ID: 85179337504    
Article
PDF
XML
Cited By:
0
0
Mini-Review

55. Targeted-release budesonide in immunoglobulin A nephropathy; a mini-review
Shiva Toumaj ORCID, Shahrzad Alimohammadi ORCID, Maryam Ghasemi ORCID, Shokouh Shayanpour* ORCID
J Nephropharmacol. 2023;12(2): e10605. doi: 10.34172/npj.2023.10605
Scopus ID: 85162004368    
Article
PDF
XML
Cited By:
0
0
News and Views

56. Promising role of sodium-glucose cotransporter-2 inhibitors in IgA nephropathy
Samaneh Zandifar ORCID, Shokouh Shayanpour* ORCID
J Nephropharmacol. 2023;12(2): e10606. doi: 10.34172/npj.2023.10606
Scopus ID: 85161967933    
Article
PDF
XML
Cited By:
0
0
Original

57. Evaluation of risk factors affecting the lifespan and efficiency of dialysis accesses installed in dialysis patients referees to Ahvaz therapeutic centers in a two-year cohort study
Afshin Bighamian ORCID, Iraj Nazari* ORCID, Seyed Masood Mousavi ORCID, Hossain Minaee ORCID
J Nephropharmacol. 2024;13(1): e10639. doi: 10.34172/npj.2023.10639
Scopus ID: 85180456772    
Article
PDF
XML
Cited By:
2
1
Review

58. Renal insufficiency in breast cancer patients; a review study
Nahid Moradi ORCID, Shahrzad Izadi ORCID, Hamid Reza Hemmati* ORCID
J Nephropharmacol. 2024;13(2): e11659. doi: 10.34172/npj.2024.11659
Scopus ID: 85197775477    
Article
PDF
XML
Cited By:
0
0
Epidemiology and Prevention

59. Oncocardiology: close collaboration between oncologists, cardiologists, and nephrologists

Sina Salati ORCID, Bahare Firouzbakht ORCID, Padideh Daneii ORCID, Ali Azarpey ORCID, Behnaz Hatami ORCID, Mohammad Mehdi Johari Moghadam ORCID, Negar Jafari* ORCID
J Nephropharmacol. 2024;13(1): e11660. doi: 10.34172/npj.2023.11660
Scopus ID: 85179326873    
Article
PDF
XML
Cited By:
2
2
Case Report

60. Management of severe hyponatremia in a chronic kidney disease patient; a case report
Anass Qasem* ORCID, Syed Arman Rabbani ORCID, Martin Thomas Kurian, Sathvik B Sridhar
J Nephropharmacol. 2024;13(2): e11674. doi: 10.34172/npj.2024.11674
Scopus ID: 85197817974    
Article
PDF
XML
Cited By:
0
0
Original

61. Determining the alteration of ghrelin and some biochemical parameters in end-stage kidney disease patients on hemodialysis
Khalid Shaalan Sahab ORCID, Mohammed Asaad Mahdi* ORCID, Ammar M. AL-Azzawi ORCID
J Nephropharmacol. 2025;14(1): e11677. doi: 10.34172/npj.2025.11677
Scopus ID: 85218224908    
Article
PDF
XML
Cited By:
0
0
Case Series

62. Twin neurological enigmas radiological and medical insight into a dual encounter with metformin induced encephalopathy
Leyole Claudine Ancilla ORCID, Bala Sundaram* ORCID, Nabadwip Pathak ORCID, Arawinth Raj ORCID
J Nephropharmacol. 2024;13(2): e11681. doi: 10.34172/npj.2024.11681
Scopus ID: 85197757266    
Article
PDF
XML
Cited By:
0
1
Meta Analysis

63. The association between the utilization of SGLT2 inhibitors and diabetic retinopathy; a systematic review and meta-analysis of cohort studies
Shahriar Barkhordari ORCID, Shahrzad Ghaffariyan ORCID, Farzin Banei ORCID, Mohammad Shirvani ORCID, Farangis yazdanjou ORCID, Sara Ghaseminejad Kermani ORCID, Mohammad Akbari ORCID, Alireza Baghaei ORCID, Mobin Mohammadtabar* ORCID
J Nephropharmacol. 2024;13(2): e12688. doi: 10.34172/npj.2024.12688
Scopus ID: 85197804266    
Article
PDF
XML
Cited By:
0
0
Meta Analysis

64. Association between triglyceride-glucose index and risk of chronic kidney disease: a systematic review and meta-analysis
Muhanad Muhussin Ali ORCID, Raed Muslim Mhaibes* ORCID, Mohammed Abdul-Mounther Othman ORCID, Qais R. Lahhob ORCID, Mohammed Jasim Qasim
J Nephropharmacol. 2024;13(2): e12692. doi: 10.34172/npj.2024.12692
Scopus ID: 85197749903    
Article
PDF
XML
Cited By:
0
0
Letter to Editor

65. Antihypertensive effects of SGLT2 inhibitors; a letter to the editor on new concepts
Rahimeh Eskandarian ORCID, Mohammad Memarian ORCID, Samira Mehrabi Pari* ORCID
J Nephropharmacol. 2024;13(2): e12700. doi: 10.34172/npj.2024.12700
Scopus ID: 85197775476    
Article
PDF
XML
Cited By:
0
0
Mini-Review

66. Dengue fever-associated glomerulonephritis; an updated narrative mini-review
Abdul Amir H. Kadhum* ORCID, Aliaa Saadoon Abdul- Razaq Al-Faraji ORCID, Sudad Jasim Mohammed ORCID, Adil Turki Al-Musawi ORCID, Maytham Ahmed AbdulAemah ORCID, Qais R. Lahhob ORCID
J Nephropharmacol. 2025;14(1): e12711. doi: 10.34172/npj.2025.12711
Scopus ID: 85217791990    
Article
PDF
XML
Cited By:
1
0
Mini-Review

67. Renoprotective efficacy of montelukast; an overview on recent advancements
Sayed Yousef Mojtahedi ORCID, Maryam Ghodsi, Paniz Pourpashang* ORCID
J Nephropharmacol. 2025;14(1): e12759. doi: 10.34172/npj.2025.12759
Scopus ID: 85218999606    
Article
PDF
XML
Cited By:
0
0
Review

68. Earthquake-related acute kidney shut down; an overview of pre-existing associated factors
Mehdi Yarahmadi ORCID, Mohammad Reza Moonesan* ORCID
J Nephropharmacol. 2025;14(2): e12777. doi: 10.34172/npj.2025.12777
Article
PDF
XML
Cited By:
Review

69. Air pollution and kidney disease; a comprehensive updated overview of recent evidence on functional and structural alterations
Iman Ghasemzadeh ORCID, Mohadeseh Javadi ORCID, Pourya Bagherian Kenari ORCID, Ali Emadzadeh ORCID, Meysam Ziaei Mehr ORCID, Elham Ahmadipour ORCID, Hossein Mardanparvar ORCID, Seyedeh Arefeh Javadi* ORCID
J Nephropharmacol. 2025;14(2): e12789. doi: 10.34172/npj.2025.12789
Article
PDF
XML
Cited By: